The Oncology Institute, Inc.
TOI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $3 | $2 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $3 | $2 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 14% | 14.7% | 4.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 13.9% | 14.6% | 16.5% | 14.6% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -9.4% | -7.9% | -11.7% | -10.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -12.1% | -14.2% | -18.8% | -13.1% |
| EPS Diluted | -0.14 | -0.15 | -0.21 | -0.14 |
| % Growth | 6.7% | 28.6% | -50% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | $0 |